Search Results - "NEUDORF, S."

A Novel Adapter Allows Short-Term LVAD Support through the Left-Ventricular Apex without Cardiopulmonary Bypass in Healthy and Failing Pig Hearts by Scheumann, J., Köster, P., Rausch, M., Benk, C., Maier, S., Neudorf, S., Diel, P., Grundmann, S., Schibilsky, D., Beyersdorf, F., Bothe, W.

“…Currently the implantation of left-ventricular assist devices (LVADs) requires the use of cardiopulmonary bypass (CPB) and access to the aorta for the…”
Get full text

Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome : Children's Cancer Group Studies 2861 and 2891 by LANGE, B. J, KOBRINSKY, N, WOODS, W. G, BARNARD, D. R, ARTHUR, D. C, BUCKLEY, J. D, HOWELLS, W. B, GOLD, S, SANDERS, J, NEUDORF, S, SMITH, F. O

“…In recent pediatric trials of acute myeloid leukemia (AML), children with Down syndrome (DS) have had significantly more megakaryoblastic leukemia and have…”
Get full text

Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival by Neudorf, Steven, Sanders, Jean, Kobrinsky, Nathan, Alonzo, Todd A., Buxton, Allen B., Gold, Stuart, Barnard, Dorothy R., Wallace, Joetta D., Kalousek, Dagmar, Lange, Beverly J., Woods, William G.

“…In Children's Cancer Group (CCG) study 2891, patients who were recently diagnosed with acute myelocytic leukemia (AML) were assigned randomly to standard- or…”
Get full text

Timed-Sequential Induction Therapy Improves Postremission Outcome in Acute Myeloid Leukemia: A Report From the Children’s Cancer Group by Woods, William G., Kobrinsky, Nathan, Buckley, Jonathan D., Lee, Jae Won, Sanders, Jean, Neudorf, Steven, Gold, Stuart, Barnard, Dorothy R., DeSwarte, Joetta, Dusenbery, Kathryn, Kalousek, Dagmar, Arthur, Diane C., Lange, Beverly J.

“…Timed sequencing of cycles of induction chemotherapy in acute myeloid leukemia (AML) has been proposed as a way to achieve maximal leukemic cell kill through…”
Get full text

Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era by ALONZO, T. A, WELLS, R. J, WOODS, W. G, LANGE, B, GERBING, R. B, BUXTON, A. B, NEUDORF, S, SANDERS, J, SMITH, F. O, FEIG, S. A

“…We reviewed consolidation therapy results and analyzed postremission outcomes for 1464 children less than 21 years old at diagnosis in five consecutive…”
Get full text

Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD by LEVINE, J. E, WILEY, J, KLETZEL, M, YANIK, G, HUTCHINSON, R. J, KOEHLER, M, NEUDORF, S

“…Between October 1995 and October 1998, 24 children aged 9 months to 17 years (median 11 years) underwent cytokine-mobilized allogeneic peripheral blood stem…”
Get full text

Autologous bone marrow transplantation for children with AML in first remission by NEUDORF, S, SANDERS, J, KALOUSEK, D, LANGE, B. J, WOODS, W. G, KOBRINSKY, N, ALONZO, T. A, BUXTON, A, BUCKLEY, J. D, HOWELLS, W, GOLD, S, BARNARD, D. R, DESWARTE, J

“…In Children's cancer group (CCG) 2891, newly diagnosed patients with AML were randomized between standard and intensive timing induction therapies. Patients in…”
Get full text

Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study by Woods, W G, Kobrinsky, N, Buckley, J, Neudorf, S, Sanders, J, Miller, L, Barnard, D, Benjamin, D, DeSwarte, J, Kalousek, D

“…Childrens Cancer Group (CCG) protocol 2861 was designed to test the feasibility of aggressively timed induction therapy followed by autologous or allogeneic…”
Get more information

Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow : results of phase II studies with long-term follow-up by BALL, E. D, WILSON, J, PHELPS, V, NEUDORF, S

“…One hundred and thirty-eight patients with AML underwent ABMT with monoclonal antibody plus complement-purged marrow between August 1984 and March 1997. One…”
Get full text

Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient by LONES, M. A, KIROV, I, SAID, J. W, SHINTAKU, I. P, NEUDORF, S

“…Post-transplant lymphoproliferative disorder (PTLD) is a complication of allogeneic bone marrow transplantation (BMT). Rare cases of PTLD after autologous BMT…”
Get full text

Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group by Barnard, D R, Kalousek, D K, Wiersma, S R, Lange, B J, Benjamin, D R, Arthur, D C, Buckley, J D, Kobrinsky, N, Neudorf, S, Sanders, J, Miller, L P, Shina, D C, Hammond, G D, Woods, W G

“…The purposes of this report are to reaffirm concordance difficulties with the acute myeloid leukemia (AML) French-American-British (FAB) classification, to…”
Get more information

Autoimmune manifestations of the wiskott-aldrich syndrome by Akman, Ipek O., Ostrov, Barbara E., Neudorf, Steven

“…To describe and review the autoimmune features and typicalmanifestations of Wiskott-Aldrich syndrome (WAS). Case series and review of the literature. Tertiary…”
Get full text

Graft Failure After an Umbilical Cord Blood Transplant in a Patient With Severe Aplastic Anemia by Neudorf, Steven M.L., Blatt, Julie, Corey, Seth, Koehler, Maria, Wollman, Michael, Rosner, Gayle, Rybka, Witold

Get full text

FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation by Koehler, M T, Howrie, D, Mirro, J, Neudorf, S, Blatt, J, Corey, S, Wollman, M, Kelly-Ekeroth, V, Reyes, J

“…Steroid-resistant graft-versus-host disease (GVHD) is an often lethal complication of bone marrow transplantation (BMT). FK506 (tacrolimus) is a new potent…”
Get more information

384: Daclizumab and Infliximab for Treatment of Steroid Resistant Acute Graft Versus Host Disease (aGVHD) in Pediatrics by Snyder, R.L, Daum, C, Klinger, E, Neudorf, S, Simpson, L

Get full text

A hereditary immunodeficiency characterized by CD8 T lymphocyte deficiency and impaired lymphocyte activation by MONAFO, W. J., POLMAR, S. H., NEUDORF, S., MATHER, A., FILIPOVICH, A. H.

“…SUMMARY An unusual form of severe combined immunodeficiency in children from two different families was associated with absence of CD8+ T lymphocytes and…”
Get full text

Prevention of CMV disease in allogeneic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy by KOEHLER, M, GEORGE, K. S, EHRLICH, G. D, MIRRO, J. JR, NEUDORF, S. M, RINALDO, C

“…Cytomegalovirus (CMV) infection can cause severe disease and mortality in recipients of allogeneic bone marrow transplants (alloBMT) when either the donor or…”
Get full text

A Phase 1 Dose-Escalation Study To Evaluate The Safety And Pharmacokinetics Of Palifermin In Pediatric Subjects With Acute Leukemias Undergoing Myeloablative Therapy And Allogeneic Hematopoietic Stem Cell Transplant by Morris, J, Neudorf, S, Moore, T, Shah, A, Graham, M, Aquino, V, Duerst, R, Neidler, M, deChateau, M, Berger, D, Morris, C

Get full text

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group by Woods, William G., Neudorf, Steven, Gold, Stuart, Sanders, Jean, Buckley, Jonathan D., Barnard, Dorothy R., Dusenbery, Kathryn, DeSwarte, Joetta, Arthur, Diane C., Lange, Beverly J., Kobrinsky, Nathan L.

“…Intensive, myelosuppressive therapy is necessary to maximize outcomes for patients with acute myeloid leukemia (AML). A comparison was made of 3 aggressive…”
Get full text

The effects of antithymocyte globulin on natural killer cells by Neudorf, S, Jones, M

“…We studied the effects of antithymocyte globulin (ATG) on natural killer (NK) cell activity to evaluate whether ATG may be useful in preventing NK-mediated…”
Get more information